Table 2.
Crude and adjusted odds ratios for outcomes of VOC infection in adult and pediatric populations
| VOC Infected | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Adults | Pediatrics | ||||||||
| Outcome |
Crude OR
(95% CI) |
p-value |
Adjusted OR
(95% CI) |
p-value |
Crude OR
(95% CI) |
p-value |
Adjusted OR
(95% CI) |
p-value | |
| Hospitalization | 2.08 (1.86–2.32) | < 0.001 | 1.54 (1.36–1.74) | < 0.001 | 1.16 (0.85–1.59) | 0.341 | 1.00 (0.69–1.44) | 0.999 | |
| Above Median hospital LOS | 4.15 (3.54–4.87) | < 0.001 | 3.53 (2.72–4.12) | < 0.001 | 0.82 (0.53–1.27) | 0.389 | 0.75 (0.45–1.25) | 0.283 | |
| Critical care admission | 3.59 (3.19–4.89) | < 0.001 | 2.69 (2.13–3.39) | < 0.001 | 0.82 (0.43–1.54) | 0.547 | 0.73 (0.37–1.45) | 0.381 | |
| Above Median CCU LOS | 7.21 (5.30–9.80) | < 0.001 | 4.74 (3.23–6.97) | < 0.001 | 0.94 (0.48–1.84) | 0.872 | 0.10 (0.33–1.49) | 0.363 | |
| Need for ventilatory support | 4.93 (3.82–6.36) | < 0.001 | 3.012 (2.30–3.94) | < 0.001 | -- | -- | -- | -- | |
| In hospital COVID-19 Mortality | 6.13 (4.22–8.82) | < 0.001 | 3.73 (2.53–5.51) | < 0.001 | -- | -- | -- | -- | |
LOS = length of stay
Bivariate analysis (Non- VOC & VOC infected) was used for the regression models, non-VOC was considered the reference group in all analyses, presented as crude OR and adjusted OR for sex, nationality, BMI, comorbidities, and vaccination status.
-- Sample size ≤ 20